Frequently Asked Questions
The market is segmented based on Global Ibuprofen API Market Segmentation, By Type (Standard Ibuprofen and High Potency Ibuprofen), Application (Headache, Arthritis, and Others), End User (CROs and CMOs and Pharmaceutical and Biopharmaceutical Company) – Industry Trends and Forecast to 2031.
.
The Global Ibuprofen Api Market size was valued at USD 448.74 USD Million in 2023.
The Global Ibuprofen Api Market is projected to grow at a CAGR of 4.9% during the forecast period of 2024 to 2031.
The major players operating in the market include BASF SE (Germany), SI Group, Inc. (U.S.), BIOCAUSE Inc. (U.S.), IOL Chemicals and Pharmaceuticals Limited (India), Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd. (China), Granules India Limited (India), LGM Pharma (U.S.), Salvavidas (India), Taj Pharmaceuticals Limited (India) .
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
